How is advanced liver disease treated?

Hepatocellular carcinoma (HCC) is a highly aggressive malignancy with a relatively high incidence in China. Because early-stage HCC often presents with nonspecific or absent symptoms, it is frequently diagnosed at an advanced stage—contributing significantly to its high mortality rate. So, how is advanced-stage liver cancer treated? Let’s explore this together.

How Is Advanced-Stage Liver Cancer Treated?

“Advanced-stage liver cancer” typically refers to end-stage hepatocellular carcinoma. Treatment focuses on nutritional support and active pharmacologic management of complications—for example, sorafenib tosylate tablets or apatinib mesylate tablets—to prolong survival.

First, actively improving the patient’s nutritional status through appropriate nutritional support is essential. In advanced HCC, multiple organ systems—particularly the liver—are often severely compromised. Consequently, many patients experience varying degrees of malnutrition. Nutritional support not only enhances quality of life but also improves tolerance for subsequent therapies.

Second, actively managing complications arising from HCC is critical. Beyond hepatic dysfunction, advanced HCC may impair other organ systems. Accordingly, tailored interventions for specific complications can significantly improve quality of life. Regarding antitumor therapy, systemic targeted agents—such as sorafenib tosylate tablets or apatinib mesylate tablets—are commonly employed in advanced HCC to deliver active, targeted treatment.

We hope the above information is helpful to you.